Company Monitoring Page for Pfizer

latest headlines for company on cafepharma

Gilead joins Pfizer and Eli Lilly in JAK Race
Bidness, ETC
Sun, 12/27/15 - 10:24 am
Tags:
Gilead Sciences, JAK inhibitors, Pfizer, Eli Lilly, filgotinib, Galapagos, Xeljanz, baricitinib
The year's top pharma marketing controversies
Medical Marketing and Media
Wed, 12/23/15 - 09:50 pm
Tags:
FDA, drug pricing, Amarin, social media, PBMs, AstraZeneca, Pfizer, Valeant Pharmaceuticals, drug ads, Afrezza
Pfizer, Merck KGaA launch two more PhIII trials for avelumab
Fierce Biotech
Tue, 12/22/15 - 10:00 pm
Tags:
Pfizer, Merck KGaA, avelumab, ovarian cancer, anti-PD-L1
Pfizer Inc Mega-Merger to Pit Bayer and Reckitt Against Each Other
Bidness, ETC
Tue, 12/22/15 - 10:48 am
Tags:
Pfizer, M&A, Bayer, Reckitt Benckiser, consumer health
Ready to step up M&A, Bayer could target big game like Pfizer's OTC unit, Zoetis
Fierce Pharma
Mon, 12/21/15 - 02:59 pm
Tags:
M&A, Bayer, Pfizer, Zoetis, OTC, animal health
Why Pfizer-Allergan Deal is a Blessing for Healthcare
Bidness, ETC
Tue, 12/15/15 - 09:53 am
Tags:
Pfizer, Allergan, M&A
Four More Reasons Why Investors Should Nix The Pfizer-Allergan Merger
Forbes
Sun, 12/13/15 - 11:27 am
Tags:
Pfizer, Allergan, M&A
Pfizer's Viagra market share in China challenged by Guangzhou Baiyunshan's 'golden spear'
Fierce Pharma
Thu, 12/10/15 - 06:30 pm
Tags:
Pfizer, Viagra, China, erectile dysfunction
Pfizer Announces FDA Acceptance of IBRANCE® (palbociclib) Supplemental New Drug Application with Priority Review in HR+, HER2- Metastatic Breast Cancer
Yahoo
Thu, 12/10/15 - 11:20 am
Tags:
Pfizer, FDA, Ibrance, priority review, metastatic breast cancer
With Paris spotlight on climate change, here's how Big Pharma stacks up
Fierce Pharma
Wed, 12/9/15 - 11:46 am
Tags:
climate change, Sanofi, Biogen, Novo Nordisk, JNJ, Pfizer, Merck, Eli Lilly, Shire, Roche, Bristol-Myers Squibb
Pfizer bets up to $1B on BioAtla's approach to immuno-oncology
Fierce Biotech
Wed, 12/9/15 - 09:39 am
Tags:
Pfizer, BioAtla, immuno-oncology
Pfizer Announces U.S. FDA Acceptance and Priority Review of Supplemental New Drug Application for XALKORI® (crizotinib) for the Treatment of Patients with ROS1-Positive Metastatic Non-Small Cell Lung Cancer
Yahoo
Tue, 12/8/15 - 11:24 am
Tags:
Pfizer, FDA, Xalkori, non-small cell lung cancer
Pfizer Awards More Than $4 Million in Grants to Further Clinical Research in Advanced Breast Cancer for 2015
Yahoo
Tue, 12/8/15 - 10:12 am
Tags:
Pfizer, R&D, breast cancer, grants
Why Acquiring Pfizer Inc Unit Makes Sense For Reckitt Benckiser
Bidness, ETC
Tue, 12/8/15 - 10:09 am
Tags:
Pfizer, consumer health, Reckitt Benckiser, M&A
[video]Theranos' Valuation, Martin Shkreli's Fiduciary Responsibility, And Can Pfizer's Tax Inversion Save U.S. Pharma?
Forbes
Sat, 12/5/15 - 12:36 pm
Tags:
Theranos, Martin Shkreli, Pfizer, Allergan, tax inversions
Reckitt Benckiser Would Look at Buying Pfizer Consumer Unit
Bloomberg
Fri, 12/4/15 - 01:44 pm
Tags:
Reckitt Benckiser, Pfizer, consumer health, M&A
Pfizer is shuttering another U.K. R&D outpost, ditching 120 jobs
Fierce Biotech
Thu, 12/3/15 - 09:49 pm
Tags:
Pfizer, UK, R&D, layoffs
Pfizer-Allergan Merger Raises Concerns That Fraud Is Part Of 'Corporate DNA'
Forbes
Thu, 12/3/15 - 09:32 pm
Tags:
Pfizer, Allergan, M&A
Troubles Ahead for the Pharmaceutical Industry
Fortune
Thu, 12/3/15 - 09:30 am
Tags:
Pfizer, Allergan, M&A, tax inversions
Pfizer & Allergan: Who’s Getting the Better Deal?
Barron's
Wed, 12/2/15 - 05:58 pm
Tags:
Pfizer, Allergan, M&A

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.